)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Nexstim (NXTMH) investor relations material
Nexstim H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary15 Aug, 2025
Executive summary
Achieved over 41.8% revenue growth in H1 2025, with net sales reaching €4.5 million, driven by strong Diagnostics and Research business growth and strategic partnerships.
Positive EBITDA of €0.2 million for the second consecutive half-year, with operating loss narrowing to €0.2 million and net loss to €0.3 million.
Strategic focus on diagnostics, therapy, research, and clinic partnerships, including major collaborations with Brainlab and Sinaptica/Synaptica Therapeutics.
Signed exclusive agreement with Sinaptica/Synaptica Therapeutics for Alzheimer's research and therapy, with €1.5 million in conditional payments expected in 2025.
Launch of the new modular NBS 6 system, combining diagnostics and therapy, is imminent or planned for H2 2025, pending regulatory approvals.
Financial highlights
Net sales rose 41.8% year-over-year to €4.5 million in H1 2025; system sales grew 80% to €2.2 million.
Recurring revenue increased 7.7% to €2.1 million; licensing revenue was €0.2 million.
Gross margin reached €3.6 million, maintaining a high 81% margin.
EBITDA was positive at €0.2 million; operating loss narrowed to €0.2 million; net loss improved to €0.3 million.
Cash balance at period end was €2.7 million, with positive operating cash flow of €0.3 million.
Outlook and guidance
Net sales expected to grow and operating result to improve for full year 2025.
Strong order backlog, record pace of system orders, and new product launches support a positive outlook.
Strategic focus on profitable growth, minimizing future capital needs, and expanding partnerships, especially in the US.
Assess Magnus Medical disagreement impact.
Explain Sinaptica exclusivity conditions.
Detail Brainlab gross margin target status.
What's the status of NBS 6 regulatory approvals?
How will Sinaptica collaboration be finalized?
Detail the impact of Brainlab partnership.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Nexstim earnings date
H2 202527 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Nexstim Plc is a public company that develops and markets non-invasive brain stimulation technologies. Nexstim Plc has developed proprietary and patented technologies that can be used to stimulate peripheral nerves, muscles, and organs of the body using externally applied magnetic fields. The Company markets its systems across the globe through a network of distributors and sales representatives. The key product from its product portfolio is Contravex™ System, which combines two leading neurostimulation technologies for pain control - nerve stimulation and vagus nerve stimulation - in the same hand-held device.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage